NRG Oncology Foundation, Inc is a Philadelphia-based organization with a rich history of over 150 years in conducting groundbreaking clinical trials and research in the field of oncology. As a leader in the industry, they have extensive experience in conducting practice-defining phase II and III trials sponsored primarily by the National Cancer Institute (NCI). Their expertise also extends to conducting phase I trials and translational biological studies, which are crucial for advancing clinical cancer research in the future.
With a focus on science and collaboration, NRG Oncology Foundation, Inc and its partners are dedicated to improving cancer care and outcomes. They provide a wide range of resources and support for patients, including genetic testing, clinical trial information, patient-reported outcomes, and access to biospecimens. Their multidisciplinary approach involves various committees and scientific core groups, ensuring comprehensive research and development in areas such as brain tumors, breast cancer, gastrointestinal cancer, genitourinary cancer, gynecologic cancer, head and neck cancer, lung cancer, and more. Through their commitment to innovation and excellence, NRG Oncology Foundation, Inc continues to make significant contributions to the field of oncology.
Generated from the website